BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Park S, Yoon WS, Rim CH. Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints. World J Gastroenterol 2020; 26(4): 393-403 [PMID: 32063688 DOI: 10.3748/wjg.v26.i4.393]
URL: https://www.wjgnet.com/1948-5182/full/v26/i4/393.htm
Number Citing Articles
1
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni. Stereotactic body radiation therapy for hepatocellular carcinoma: from infancy to ongoing maturity.JHEP Reports 2022; : 100498 doi: 10.1016/j.jhepr.2022.100498
2
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysisJournal of Hepato-Biliary-Pancreatic Sciences 2021; 28(12): 1031 doi: 10.1002/jhbp.865
3
Marie Cantaloube, Florence Castan, Morgane Creoff, Jessica Prunaretty, Karl Bordeau, Morgan Michalet, Eric Assenat, Boris Guiu, Georges-Philippe Pageaux, Marc Ychou, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou. Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaCancers 2021; 13(19): 4853 doi: 10.3390/cancers13194853
4
Chai Hong Rim, Jason Cheng, Wen-Yen Huang, Tomoki Kimura, Victor Lee, Zhao-Chong Zeng, Jinsil Seong. An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspectiveRadiotherapy and Oncology 2020; 148: 73 doi: 10.1016/j.radonc.2020.03.027
5
Belal Abousaida, Danushka Seneviratne, Bradford S Hoppe, Stephen J Ko, Aroumougame Asaithamby, Francis A Cucinotta, Jessica M Kirwan, Kabir Mody, Beau Toskich, Jonathan B Ashman, Christopher L Hallemeier, Sunil Krishnan. Carbon Ion Radiotherapy in the Management of Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2021; : 1169 doi: 10.2147/JHC.S292516
6
Sunmin Park, Won Sup Yoon, Mi Hee Jang, Chai Hong Rim. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinomaInternational Journal of Radiation Biology 2020; 96(12): 1541 doi: 10.1080/09553002.2020.1830316
7
Chai Hong Rim. Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinomaJournal of Liver Cancer 2021; 21(2): 113 doi: 10.17998/jlc.2021.05.26
8
Ibrahim Chamseddine, Yejin Kim, Brian De, Issam El Naqa, Dan G. Duda, John Wolfgang, Jennifer Pursley, Harald Paganetti, Jennifer Wo, Theodore Hong, Eugene J. Koay, Clemens Grassberger. Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After RadiotherapyJCO Clinical Cancer Informatics 2022; (6) doi: 10.1200/CCI.21.00169
9
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment CriteriaSeminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
10
P. Giraud, D. Lerouge, I. Latorzeff, X. Mirabel, A. Dohan, P. Mordant, N. Barry de Longchamps. Radiothérapie stéréotaxique des tumeurs primitives extracrâniennesCancer/Radiothérapie 2020; 24(6-7): 513 doi: 10.1016/j.canrad.2020.06.020
11
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge. MiR-122 radiosensitize hepatocellular carcinoma cells by suppressing cyclin G1International Journal of Radiation Biology 2022; 98(1): 11 doi: 10.1080/09553002.2021.1987561
12
Chai Hong Rim. Response to Letter to the Editor by Johnston and Fotiadis regarding “Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.”Radiotherapy and Oncology 2021; 154: e6 doi: 10.1016/j.radonc.2020.05.027
13
Chai Hong Rim, Hye Yoon Lee, Jung Sun Kim, Hakyoung Kim. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?International Journal of Radiation Biology 2021; 97(2): 111 doi: 10.1080/09553002.2021.1857453
14
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge. Silencing the Expression of Cyclin G1 Enhances the Radiosensitivity of Hepatocellular Carcinoma In Vitro and In Vivo by Inducing ApoptosisRadiation Research 2021; 195(4) doi: 10.1667/RADE-20-00180.1
15
S. Lewis, A. Barry, M.A. Hawkins. Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation SizeClinical Oncology 2022; 34(5): e195 doi: 10.1016/j.clon.2022.02.021
16
Yi Liu, Mu Qi, Lianchang Liu, Mengke Li, Hao Feng, Yuhan Gan, Shumei Ma, Xiaodong Liu. Blocking Adipor1 enhances radiation sensitivity in Hepatoma Carcinoma CellsArchives of Biochemistry and Biophysics 2022; 718: 109152 doi: 10.1016/j.abb.2022.109152
17
Kyung Su Kim, Hong-Gyun Wu. Who Will Benefit from Charged-Particle Therapy?Cancer Research and Treatment 2021; 53(3): 621 doi: 10.4143/crt.2021.299
18
Chai Hong Rim, Jinsil Seong. Radiotherapy of Liver Cancer2021; : 155 doi: 10.1007/978-981-16-1815-4_11